Journal Report

Expert Opinion on Investigational Drugs

Download PDF
Journal Information
Journal Title
Expert Opinion on Investigational Drugs
Publisher
Taylor and Francis Ltd.
ISSN
1354-3784
E-ISSN
1744-7658
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Targeting MUC1 in colorectal cancer
Yier Lu, Ning Zhu, Ying Yuan
2026-11-3 Pages 1-4
DOI: 10.1080/13543784.2026.2754908
Designing for success in early-phase hemophilia clinical trials: historical lessons and emerging principles for next-generation therapeutics
Johnny N. Mahlangu
2026-10-28 Pages 1-14
DOI: 10.1080/13543784.2026.2754085
Zovegalisib for <i>PIK3CA</i> -driven vascular and lymphatic malformations: a drug evaluation
Emmanuel Seront, An Van Damme, Julien Coulie et al.
2026-10-17 Pages 1-8
DOI: 10.1080/13543784.2026.2750463
Targeting the proteasome in <i>Leishmania donovani</i> : developments from preclinical to Phase I and II trials
Shyam Sundar, Sarita Singh, Priya Maurya et al.
2026-10-3 Vol. 35 Issue 10 Pages 735-750
DOI: 10.1080/13543784.2026.2750461
Dual antigen targeting in extramedullary multiple myeloma
Binish Javed, Shaji Kumar
2026-10-3 Vol. 35 Issue 10 Pages 685-689
DOI: 10.1080/13543784.2026.2746598
Evaluating early systemic therapies in the neoadjuvant setting for the treatment of urological cancers
Panagiotis Velissarios Stamatakos, Charalampos Fragkoulis, Nikolaos Kontolatis et al.
2026-10-3 Vol. 35 Issue 10 Pages 705-714
DOI: 10.1080/13543784.2026.2748359
Safety, pharmacokinetics, pharmacodynamics and target-mediated drug disposition modeling of TST002, a sclerostin antibody, in men and postmenopausal women with low bone mineral density
Sufeng Zhou, Xiufen Zhu, Yuchen Sheng et al.
2026-9-22 Vol. 35 Issue 10 Pages 751-765
DOI: 10.1080/13543784.2026.2736007
Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma
Carlos Torrado, Anthony P. Conley
2026-9-20 Vol. 35 Issue 10 Pages 691-704
DOI: 10.1080/13543784.2026.2734584
Innovative therapies under clinical development for ALS treatment. Part 2: biologics and natural products
Chi-Chen Sarah Huang, Cecilia Sanchez-Santos, Loreto Martinez-Gonzalez et al.
2026-9-12 Vol. 35 Issue 10 Pages 715-733
DOI: 10.1080/13543784.2026.2729512
Varespladib for snakebite envenoming: insights from therapeutic development and clinical trials
Madison R. McGann, Timothy F. Platts-Mills, Charles J. Gerardo
2026-9-2 Vol. 35 Issue 9 Pages 657-666
DOI: 10.1080/13543784.2026.2727499
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 8, 2026 01:22